hotspot -WSS

hotspot

author：explore 2025-09-30 20:05:46 - browse：945

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Hospital chaplains balance Covid safety with patients’ spiritual needs

WSS

Patient advocates debate FDA's accelerated approval process

Patient advocates debate FDA's accelerated approval process

A preacher's new calling: Diversifying neuroscience research

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

The Readout: Lenmeldy, GLP

focus

hotspot

focus

New air purifier tech could be key to improving indoor air quality

Primary care physicians play key roles in Alzheimer's management

Drug repurposing or repositioning? The language matters

Supreme Court mifepristone arguments center on docs' right to sue

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Roche subsidiary Foundation Medicine opens new headquarters

Novavax promises a turnaround & Lilly roils the obesity market

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

23andMe had bad news about my health. I wish a person had delivered it

Why the world’s most expensive drug might be worth the price

focus

Washington mulls new rules to avert another Change Healthcare

Why the world’s most expensive drug might be worth the price

Readout Newsletter: Merck, Vertex, and Viking updates

Steward Health Care has deal to sell doctor network to UnitedHealth

Primary care physicians play key roles in Alzheimer's management

Readout Newsletter: Merck, Vertex, and Viking updates

leisure time

explore

knowledge

explore